BRIVAHENZ 75 10'S

About

Brivahenz is an antiepileptic drug (AED) used in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy. Its precise mechanism of action is thought to involve high-affinity binding to synaptic vesicle protein 2A (SV2A) in the brain. This binding is believed to modulate neurotransmitter release, thereby reducing neuronal excitability and preventing the excessive electrical activity that leads to seizures.

By selectively targeting SV2A, Brivahenz helps to stabilize nerve cell activity and reduce the frequency and severity of seizures. It is often used as an add-on therapy when other antiepileptic medications have not provided adequate control, offering a targeted approach to managing epilepsy and improving the quality of life for affected individuals.

Uses

• Treatment of partial-onset seizures in epilepsy
• Adjunctive therapy for uncontrolled seizures
• Reduction of seizure frequency
• Improvement in seizure control

Directions For Use

Take orally with or without food, exactly as prescribed by your doctor, usually twice daily.

Benefits

• Effective in controlling partial-onset seizures
• Well-tolerated by many patients
• Can be used as add-on therapy
• Helps improve quality of life for epilepsy patients
• Relatively rapid onset of action
• Available in different strengths for flexible dosing

Side Effects

• Drowsiness or fatigue
• Dizziness
• Nausea and vomiting
• Irritability
• Insomnia
• Headache
• Nasopharyngitis (common cold symptoms)
• Constipation
• Depression or mood changes
• Anxiety
• Suicidal ideation (rare but serious)
• Coordination problems

Safety Measures

• Alcohol - Alcohol can enhance the central nervous system depressant effects of Brivahenz, leading to increased drowsiness and dizziness. Avoid or limit alcohol consumption.
• Pregnancy - Brivahenz should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Consult your doctor for personalized advice.
• Breastfeeding - Brivahenz is excreted in human milk. A decision should be made whether to discontinue breastfeeding or to discontinue the drug, considering the importance of the drug to the mother.
• Liver - Patients with impaired liver function may require dosage adjustments for Brivahenz. Close monitoring of liver function is recommended.
• Kidney - Dosage adjustments may be necessary for patients with severe kidney impairment. Renal function should be monitored as appropriate.
• Lung - No specific direct adverse effects on lung function are commonly associated with Brivahenz. However, general caution applies to all medications.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.